The purpose of this randomized clinical trial is to treat patients with small to mid-sized
abdominal aortic aneurysms (AAA), maximum diameter of 3.5 cm to 5.0 cm, using a locally
delivered, single-dose endovascular treatment. The main question the study aims to answer is
to demonstrate efficacy of the product for stabilization of these small to mid-sized AAA.The
study will compare the treatment group to the typical standard of care for these patients,
surveillance. All subjects will be followed at designated intervals at 30/60 days, 6, 12, 18
and 24 months with continued follow-up annually for up to 5 years.